Charité's work in the field of immunology is characterized by its international focus and interdisciplinary approach. With an enviable level of expertise in both basic and clinical research, Charité can ensure that findings are quickly translated into clinical practice, where they can be used for the benefit of patients.

You are here:

The Research Center ImmunoSciences (RCIS)

Interdisciplinary and application oriented network of researchers in the field of immunology at the Charité

  • Interaction, cooperation and technology expertise exchange between junior scientists, established scientists and clinicians
  • Excellent immunological research in national and international consortia
  • Applied and translational prae-clinical and clinical research
  • Cooperation with industrial partners
  • Commercialisation by product development, patenting and spin-off companies

Competence in the fight against inflammatory bowel disorders

Chronic inflammatory bowel disease (IBD) is one of the main areas of research focus within the field of immunology. Therefore, in the areas of diagnosis, treatment, and research, Charité – Universitätsmedizin Berlin is able to offer something that very few other centers in Germany can com-pete with. This is what makes Charité one of the three pillars of the IBD Competence Network – a nationwide network of departments, university-based institutes, and private specialists who have joined together to conduct research into two chronic inflammatory bowel diseases – Crohn's dis-ease and ulcerative colitis. Charité is committed to the development and successful long-term im-plementation of research-based clinical guidelines for the treatment of both of these disorders.

At Charité, all research activities in the area of chronic inflammatory bowel disease are being con-ducted under the auspices of a dedicated Collaborative Research Center. Research priorities in-clude the bowel's immune system, as well as studies that investigate the way in which the gastroin-testinal tract protects the body against potential contamination by pathogens. The aim of this re-search is to use new research findings in order to help strengthen the body's own defense mecha-nisms, thus preventing chronic inflammation. The close cooperation between basic research, clini-cal research, and patient-centered research allows new research findings to be quickly translated into clinical practice.

Specialist expertise in rheumatology

In the field of rheumatology, Charité's special areas of research focus include joint disorders and systemic autoimmune diseases, such as rheumatoid arthritis, inflammatory disorders of the spine, and systemic sclerosis. Aside from causing considerable impairment, these disorders also have a significant socio-economic impact; the fact that they tend to occur in younger people means that there are also implications for health care policy. In the field of rheumatology, Charité has a par-ticularly keen interest in the areas of diagnosis, treatment, and research.

In addition to providing general rheumatology-based diagnosis and treatment services through both its inpatient and outpatient facilities, Charité – Universitätsmedizin Berlin also offers the option of participation in national and international clinical trials, thereby giving patients access to innova-tive new treatment methods. A large number of these are Charité-initiated trials, meaning that Charité is responsible for both planning and conduct. These clinical trials build on findings from Charité's basic research endeavors, which benefit from having close links with the German Rheu-matism Research Center. With the support of the German Research Foundation (DFG), the Fed-eral Ministry of Education and Research, and the EU, as well as other foundations and industrial partners, researchers at Charité are able to produce rheumatology- and immunology-based re-search of a very high standard, and have an impact on both the national and international stage.